NO20072854L - Acylerte nonadepsipeptider anvendt som lysobaktinderivater - Google Patents
Acylerte nonadepsipeptider anvendt som lysobaktinderivaterInfo
- Publication number
- NO20072854L NO20072854L NO20072854A NO20072854A NO20072854L NO 20072854 L NO20072854 L NO 20072854L NO 20072854 A NO20072854 A NO 20072854A NO 20072854 A NO20072854 A NO 20072854A NO 20072854 L NO20072854 L NO 20072854L
- Authority
- NO
- Norway
- Prior art keywords
- nonadepsipeptides
- acylated
- derivatives
- lysobactin
- lysobactin derivatives
- Prior art date
Links
- KQMKBWMQSNKASI-AVSFGBOWSA-N lysobactin Chemical class O1C(=O)[C@H](CO)NC(=O)[C@H]([C@H](O)C(N)=O)NC(=O)CNC(=O)[C@H]([C@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@H](O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](N)CC(C)C)[C@H]1C1=CC=CC=C1 KQMKBWMQSNKASI-AVSFGBOWSA-N 0.000 title abstract 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 125000001980 alanyl group Chemical group 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000005445 natural material Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004053407A DE102004053407A1 (de) | 2004-11-05 | 2004-11-05 | Acylierte Nonadepsipeptide II |
| PCT/EP2005/011363 WO2006048139A1 (fr) | 2004-11-05 | 2005-10-22 | Nonadepsipeptides acyles sous forme de derives de lysobactine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072854L true NO20072854L (no) | 2007-08-01 |
Family
ID=35462537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072854A NO20072854L (no) | 2004-11-05 | 2007-06-05 | Acylerte nonadepsipeptider anvendt som lysobaktinderivater |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7531507B2 (fr) |
| EP (1) | EP1807443A1 (fr) |
| JP (1) | JP4843614B2 (fr) |
| KR (1) | KR20070083984A (fr) |
| CN (1) | CN101056887A (fr) |
| AR (1) | AR053775A1 (fr) |
| AU (1) | AU2005300815B2 (fr) |
| BR (1) | BRPI0516677A (fr) |
| CA (1) | CA2586704A1 (fr) |
| CR (1) | CR9079A (fr) |
| DE (1) | DE102004053407A1 (fr) |
| GT (1) | GT200500308A (fr) |
| HN (1) | HN2005030779A (fr) |
| IL (1) | IL182739A (fr) |
| MA (1) | MA29218B1 (fr) |
| MX (1) | MX2007005382A (fr) |
| MY (1) | MY145448A (fr) |
| NO (1) | NO20072854L (fr) |
| NZ (1) | NZ554813A (fr) |
| PE (1) | PE20060942A1 (fr) |
| RU (1) | RU2414477C2 (fr) |
| SV (1) | SV2006002290A (fr) |
| TW (1) | TW200621799A (fr) |
| UA (1) | UA89800C2 (fr) |
| UY (1) | UY29189A1 (fr) |
| WO (1) | WO2006048139A1 (fr) |
| ZA (1) | ZA200703674B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004051023A1 (de) * | 2004-10-20 | 2006-05-04 | Bayer Healthcare Ag | Desoxo-Nonadepsipeptide |
| DE102004051025A1 (de) * | 2004-10-20 | 2006-04-27 | Bayer Healthcare Ag | Substituierte Nonadepsipeptide |
| DE102004051024A1 (de) * | 2004-10-20 | 2006-04-27 | Bayer Healthcare Ag | Heterocyclyl-substituierte Nonadepsipeptide |
| DE102004053410A1 (de) * | 2004-11-05 | 2006-05-11 | Bayer Healthcare Ag | Cyclische Nonadepsipeptidamide |
| DE102006003443A1 (de) * | 2006-01-25 | 2007-07-26 | Aicuris Gmbh & Co. Kg | Asparagin-10-substituierte Nonadepsipeptide |
| DE102006018080A1 (de) * | 2006-04-13 | 2007-10-18 | Aicuris Gmbh & Co. Kg | Lysobactinamide |
| DE102006018250A1 (de) * | 2006-04-13 | 2007-10-18 | Aicuris Gmbh & Co. Kg | Verfahren zum Herstellen von cyclischen Depsipeptiden |
| TW201717991A (zh) | 2015-08-17 | 2017-06-01 | 拜耳動物保健有限公司 | 用於治療牛乳房炎之溶桿菌素 |
| ES2941969T3 (es) * | 2015-10-23 | 2023-05-29 | Navitor Pharm Inc | Moduladores de la interacción de Sestrina-GATOR2 y sus usos |
| EP3363452A1 (fr) * | 2017-02-17 | 2018-08-22 | Bayer Animal Health GmbH | Combinaisons de lysobactine et d'aminoglycosides contre des maladies provoquées par des bactéries à gram positif et à gram négatif chez des animaux non humains |
| ES3040534T3 (en) | 2017-04-26 | 2025-11-03 | Navitor Pharm Inc | Modulator of sestrin-gator2 interaction for use in the treatment of treatment-resistant depression |
| IL292612A (en) | 2019-11-01 | 2022-07-01 | Navitor Pharm Inc | Treatment methods using mtorc1 modulator |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1266247A (fr) | 1985-03-25 | 1990-02-27 | Adrienne A. Tymiak | Antibiotique prepare par lysobacter sp. sc14,067 |
| JPH01132600A (ja) | 1987-11-17 | 1989-05-25 | Shionogi & Co Ltd | カタノシンａおよびｂならびにその製造法 |
| DE10320781A1 (de) * | 2003-05-09 | 2004-11-25 | Bayer Healthcare Ag | Acylierte Nonadepsipeptide |
-
2004
- 2004-11-05 DE DE102004053407A patent/DE102004053407A1/de not_active Withdrawn
-
2005
- 2005-10-22 CN CNA2005800371138A patent/CN101056887A/zh active Pending
- 2005-10-22 EP EP05798234A patent/EP1807443A1/fr not_active Withdrawn
- 2005-10-22 BR BRPI0516677-2A patent/BRPI0516677A/pt not_active Application Discontinuation
- 2005-10-22 NZ NZ554813A patent/NZ554813A/en not_active IP Right Cessation
- 2005-10-22 AU AU2005300815A patent/AU2005300815B2/en not_active Ceased
- 2005-10-22 KR KR1020077010212A patent/KR20070083984A/ko not_active Ceased
- 2005-10-22 RU RU2007120686/04A patent/RU2414477C2/ru not_active IP Right Cessation
- 2005-10-22 CA CA002586704A patent/CA2586704A1/fr not_active Abandoned
- 2005-10-22 WO PCT/EP2005/011363 patent/WO2006048139A1/fr not_active Ceased
- 2005-10-22 UA UAA200705852A patent/UA89800C2/ru unknown
- 2005-10-22 MX MX2007005382A patent/MX2007005382A/es active IP Right Grant
- 2005-10-22 JP JP2007539492A patent/JP4843614B2/ja not_active Expired - Fee Related
- 2005-10-22 ZA ZA200703674A patent/ZA200703674B/xx unknown
- 2005-10-27 GT GT200500308A patent/GT200500308A/es unknown
- 2005-11-02 MY MYPI20055197A patent/MY145448A/en unknown
- 2005-11-02 AR ARP050104586A patent/AR053775A1/es unknown
- 2005-11-03 UY UY29189A patent/UY29189A1/es unknown
- 2005-11-03 HN HN2005030779A patent/HN2005030779A/es unknown
- 2005-11-04 PE PE2005001295A patent/PE20060942A1/es not_active Application Discontinuation
- 2005-11-04 SV SV2005002290A patent/SV2006002290A/es not_active Application Discontinuation
- 2005-11-04 TW TW094138656A patent/TW200621799A/zh unknown
- 2005-11-04 US US11/267,063 patent/US7531507B2/en not_active Expired - Fee Related
-
2007
- 2007-04-20 CR CR9079A patent/CR9079A/es not_active Application Discontinuation
- 2007-04-23 IL IL182739A patent/IL182739A/en not_active IP Right Cessation
- 2007-05-30 MA MA29955A patent/MA29218B1/fr unknown
- 2007-06-05 NO NO20072854A patent/NO20072854L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20060942A1 (es) | 2006-10-20 |
| UY29189A1 (es) | 2006-06-30 |
| IL182739A (en) | 2013-03-24 |
| MY145448A (en) | 2012-02-15 |
| WO2006048139A1 (fr) | 2006-05-11 |
| US20060264358A1 (en) | 2006-11-23 |
| DE102004053407A1 (de) | 2006-05-11 |
| MX2007005382A (es) | 2007-08-14 |
| AR053775A1 (es) | 2007-05-23 |
| BRPI0516677A (pt) | 2008-09-16 |
| KR20070083984A (ko) | 2007-08-24 |
| AU2005300815B2 (en) | 2011-05-19 |
| AU2005300815A1 (en) | 2006-05-11 |
| GT200500308A (es) | 2006-06-02 |
| SV2006002290A (es) | 2006-10-13 |
| JP4843614B2 (ja) | 2011-12-21 |
| ZA200703674B (en) | 2008-09-25 |
| IL182739A0 (en) | 2007-07-24 |
| EP1807443A1 (fr) | 2007-07-18 |
| RU2414477C2 (ru) | 2011-03-20 |
| HN2005030779A (es) | 2010-08-19 |
| NZ554813A (en) | 2009-11-27 |
| RU2007120686A (ru) | 2008-12-10 |
| TW200621799A (en) | 2006-07-01 |
| CA2586704A1 (fr) | 2006-05-11 |
| US7531507B2 (en) | 2009-05-12 |
| JP2008518982A (ja) | 2008-06-05 |
| UA89800C2 (en) | 2010-03-10 |
| CN101056887A (zh) | 2007-10-17 |
| MA29218B1 (fr) | 2008-02-01 |
| CR9079A (es) | 2007-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072854L (no) | Acylerte nonadepsipeptider anvendt som lysobaktinderivater | |
| NO20044618L (no) | Dedifferensierte, programmerbare stamceller av monocyttisk opprinnelse og deres fremstilling og anvendelse | |
| NO20045521L (no) | Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer | |
| NO20080745L (no) | Nye peptider for anvendelse i behandling av fedme | |
| NO20083324L (no) | Multisykliske aminosyrederivater og anvendelse derav | |
| TW200716646A (en) | (S)-N-methylnaltrexone | |
| NO20092023L (no) | Oligoribonuleotider og anvendelser derav | |
| NO20091413L (no) | WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser | |
| NO20073664L (no) | Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet | |
| CY1116768T1 (el) | Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων | |
| MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
| NO20074441L (no) | 1-benzylindol-2-karboksamidderivater | |
| DK1636236T3 (da) | Pyrazolo-quinazolin-derivater, en fremgangsmåde til fremstilling deraf, og deres anvendelse som kinase-inhibitorer | |
| NO20055894L (no) | Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer | |
| MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
| EP2114925A4 (fr) | Analogues azétidine d'inhibiteurs de nucléosidase et de phosphorylase | |
| WO2005013892A3 (fr) | Agents therapeutiques contenant du bore et a resistance hydrolytique et procedes pour les utiliser | |
| NO20081844L (no) | Terapeutiske forbindelser | |
| NO20084852L (no) | MGLUR5 modulatorer V | |
| NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
| NO20075815L (no) | Formuleringer og metoder for behandling av amyloidose | |
| MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
| NO20072290L (no) | Organiske forbindelser. | |
| JO2229B1 (en) | Stem cells are programmable, distinctly regenerative, of single-core cell origin, production, and use | |
| CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |